Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Common Equity: 2021-2024

Historic Common Equity for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to $1.4 billion.

  • LifeStance Health's Common Equity rose 387.23% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 387.23%. This contributed to the annual value of $1.4 billion for FY2024, which is 121.45% up from last year.
  • LifeStance Health's Common Equity amounted to $1.4 billion in FY2024, which was up 121.45% from $1.4 billion recorded in FY2023.
  • Over the past 5 years, LifeStance Health's Common Equity peaked at $1.5 billion during FY2021, and registered a low of $1.4 billion during FY2023.
  • Over the past 4 years, LifeStance Health's median Common Equity value was $1.5 billion (recorded in 2022), while the average stood at $1.5 billion.
  • As far as peak fluctuations go, LifeStance Health's Common Equity tumbled by 591.24% in 2023, and later surged by 121.45% in 2024.
  • Over the past 4 years, LifeStance Health's Common Equity (Annual) stood at $1.5 billion in 2021, then decreased by 1.7% to $1.5 billion in 2022, then fell by 5.91% to $1.4 billion in 2023, then increased by 1.21% to $1.4 billion in 2024.
  • Its last three reported values are $1.4 billion in FY2024, $1.4 billion for FY2023, and $1.5 billion during FY2022.